Open·Ingested today, not yet re-verified. Deadlines can change; confirm on the official page.
Improving The Capacity of Tribal Communities to Identify Emerging Drug Threats
Office of National Drug Control Policy
Go to the official application
Free. Verify your email, then we send one reminder only.
- Posted
- Aug 14, 2026
- Amount
- $300,000
- Closes
- Aug 31, 2026 (in 16 days)
Similar opportunities open now
- Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Dec 2027
- Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Dec 2027
- Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)OpenNational Institutes of HealthCloses Jan 2027
- Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Feb 2028
- Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)OpenNational Institutes of HealthCloses Mar 2027
Classification and identifiers
- Solicitation number
- RD-ET-RDA-26-001
- Assistance listing (CFDA)
- 95.007
Amount
$300,000
Who can apply
Hospitals
About this opportunity
This project would fund researchers to address key impediments or challenges that Tribal communities face related to their capacity to identify emerging drug threats and conduct a pilot project to help these communities improve their capacity to detect and respond to emerging drug threats.
Related opportunities
- Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)National Institutes of HealthCloses Dec 2027
- Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)National Institutes of HealthCloses Dec 2027
- Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)National Institutes of HealthCloses Jan 2027
- Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)National Institutes of HealthCloses Feb 2028
- Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)National Institutes of HealthCloses Mar 2027
- Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)National Institutes of HealthCloses Nov 2027Up to $300K